Failure of antithymocyte serum postgrafting to overcome "resistance" to DLA-nonidentical canine marrow grafts.
Storb
R
R
Division of Oncology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Raff
R F
RF
Appelbaum
F R
FR
Schuening
F
F
Sandmaier
B
B
Shulman
H
H
Deeg
H J
HJ
Graham
T
T
D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D004285:Dogs / Q000276:immunology*; D006084:Graft Rejection; D006649:Histocompatibility Antigens / Q000276:immunology*; D015395:Histocompatibility Antigens Class I; D008212:Lymphocyte Depletion; D011828:Radiation Chimera; D013601:T-Lymphocytes / Q000276:immunology
D000961:Antilymphocyte Serum; D006649:Histocompatibility Antigens; D015395:Histocompatibility Antigens Class I; C039692:histocompatibility antigen DLA